Bridgeway Capital Management, LLC Repligen Corp Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $1.2 Million - $1.61 Million	-8,560 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $2.55 Million - $3.14 Million	-10,300 Reduced 54.61%	8,560 $2.27 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $1.01 Million - $1.68 Million	-5,190 Reduced 21.58%	18,860 $5.45 Million
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $24,880 - $33,142	-150 Reduced 0.62%	24,050 $4.8 Million
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $1.86 Million - $2.33 Million	10,300 Added 74.1%	24,200 $4.71 Million
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $1.7 Million - $2.2 Million	13,900 New	13,900 $2.05 Million

486

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.71B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.